Higher Dose Of Xeljanz Tied To Blood Clots In Lungs Death In RA Patients

Higher Dose Of Xeljanz Tied To Blood Clots In Lungs, Death In RA Patients

21:35 EST 25 Feb 2019 | RTTNews

There is an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of Pfizer Inc's (PFE) Xeljanz or Xeljanz XR is used in patients with rheumatoid arthritis, warns the FDA.

More From BioPortfolio on "Higher Dose Of Xeljanz Tied To Blood Clots In Lungs, Death In RA Patients"